Endogenous Bok is stable at the endoplasmic reticulum membrane and does not mediate proteasome inhibitor-induced apoptosis.
Autor: | Bonzerato CG; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Keller KR; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Schulman JJ; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Gao X; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Szczesniak LM; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Dec 19; Vol. 10, pp. 1094302. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022). |
DOI: | 10.3389/fcell.2022.1094302 |
Abstrakt: | Controversy surrounds the cellular role of the Bcl-2 family protein Bok. On one hand, it has been shown that all endogenous Bok is bound to inositol 1,4,5-trisphosphate receptors (IP Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Bonzerato, Keller, Schulman, Gao, Szczesniak and Wojcikiewicz.) |
Databáze: | MEDLINE |
Externí odkaz: |